Advanced Biomed Common Stock Performance
| ADVB Stock | 0.35 0 1.09% |
The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Advanced Biomed will likely underperform. At this point, Advanced Biomed Common has a negative expected return of -0.0431%. Please make sure to confirm Advanced Biomed's potential upside and the relationship between the daily balance of power and relative strength index , to decide if Advanced Biomed Common performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Advanced Biomed Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Advanced Biomed is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Does Pernod Ricard SA stock trade below intrinsic value - Stock Surge Community Shared Stock Ideas - nchmf.gov.vn | 10/17/2025 |
2 | Advanced Biomed registers 40M shares for potential 25M equity line - MSN | 10/22/2025 |
3 | Orchestra BioMed and Terumo Enter into New 30 Million Virtue SAB Strategic Agreements - The Manila Times | 10/28/2025 |
4 | Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - The Manila Times | 11/10/2025 |
5 | Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - Sahm | 12/11/2025 |
6 | Lexaria releases additional results from Phase 1b study GLP-1-H24-4 - Yahoo Finance | 12/31/2025 |
| Begin Period Cash Flow | 80.4 K | |
| Total Cashflows From Investing Activities | -985.00 |
Advanced Biomed Relative Risk vs. Return Landscape
If you would invest 42.00 in Advanced Biomed Common on October 11, 2025 and sell it today you would lose (6.72) from holding Advanced Biomed Common or give up 16.0% of portfolio value over 90 days. Advanced Biomed Common is currently does not generate positive expected returns and assumes 7.0413% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Advanced, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Advanced Biomed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Biomed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Advanced Biomed Common, and traders can use it to determine the average amount a Advanced Biomed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0061
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADVB |
Based on monthly moving average Advanced Biomed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Advanced Biomed by adding Advanced Biomed to a well-diversified portfolio.
Advanced Biomed Fundamentals Growth
Advanced Stock prices reflect investors' perceptions of the future prospects and financial health of Advanced Biomed, and Advanced Biomed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Advanced Stock performance.
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 4.95 M | ||||
| Shares Outstanding | 21.64 M | ||||
| Price To Book | 2.52 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (181.46 K) | ||||
| Earnings Per Share | (0.17) X | ||||
| Market Capitalization | 7.57 M | ||||
| Total Asset | 6.51 B | ||||
| Retained Earnings | (19.23 B) | ||||
| Working Capital | 318.65 K | ||||
About Advanced Biomed Performance
By analyzing Advanced Biomed's fundamental ratios, stakeholders can gain valuable insights into Advanced Biomed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Advanced Biomed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Advanced Biomed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (165.53) | (173.81) |
Things to note about Advanced Biomed Common performance evaluation
Checking the ongoing alerts about Advanced Biomed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Advanced Biomed Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Advanced Biomed generated a negative expected return over the last 90 days | |
| Advanced Biomed has high historical volatility and very poor performance | |
| Advanced Biomed has some characteristics of a very speculative penny stock | |
| Advanced Biomed has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (101.52 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Advanced Biomed generates negative cash flow from operations | |
| Advanced Biomed has a frail financial position based on the latest SEC disclosures | |
| About 78.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Lexaria releases additional results from Phase 1b study GLP-1-H24-4 - Yahoo Finance |
- Analyzing Advanced Biomed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Advanced Biomed's stock is overvalued or undervalued compared to its peers.
- Examining Advanced Biomed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Advanced Biomed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Advanced Biomed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Advanced Biomed's stock. These opinions can provide insight into Advanced Biomed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Advanced Stock analysis
When running Advanced Biomed's price analysis, check to measure Advanced Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomed is operating at the current time. Most of Advanced Biomed's value examination focuses on studying past and present price action to predict the probability of Advanced Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomed's price. Additionally, you may evaluate how the addition of Advanced Biomed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |